ConnectM Q1 FY26 net loss narrows 1.04% to $6.95 million; revenue falls 9% to $8.17 million

ConnectM Technology Solutions, Inc.
Contineum Therapeutics, INC.

ConnectM Technology Solutions, Inc.

CNTMD

0.00

Contineum Therapeutics, INC.

CNTM

0.00
  • ConnectM posted a net loss of $6.95 million, narrowing from $7.02 million a year earlier.
  • Revenue fell 9% to $8.17 million, reflecting lower Owned Service Network and Managed Solutions activity amid divestitures and wind-downs.
  • Gross margin dropped 10.7 percentage points to 23% as mix shifted toward lower-margin Logistics and new Keen Labs product sales.
  • Operating loss improved 1.48% to $3.23 million as selling, general and administrative expense fell 19% to $5.09 million.
  • Keen Labs recorded about $1.85 million of product sales to Sun Solar; cash was $2.47 million with a $27.42 million working capital deficit.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ConnectM Technology Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-066196), on May 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.